A phase Ⅱ prospective trial of photobiomodulation therapy in limiting oral mucositis in the treatment of locally advanced head and neck cancer patients

A phase Ⅱ prospective trial of photobiomodulation therapy in limiting oral mucositis in the treatment of locally advanced head and neck cancer patients

Abstract Objective This study aimed to compare the historical incidence rate of severe oral mucositis (OM) in head and neck cancer patients undergoing definitive concurrent chemoradiation therapy (CRT) versus a prospective cohort of patients with locally advanced head and neck squamous cell carcinom...

Full description

Bibliographic Details
Main Authors: Janielle K.‐A. Taylor, Leila J. Mady, Khalil Baddour, Uzoma K. Iheagwara, Shuyan Zhai, James P. Ohr, Daniel P. Zandberg, Vikram C. Gorantla, Robert L. Ferris, Seungwon Kim, Umamaheswar Duvvuri, Mark W. Kubik, Shaum Sridharan, Jonas T. Johnson, Karen D. Holeva, Annette E. Quinn, David A. Clump
Format: Article
Language:English
Published: Wiley 2022-12-01
Series:World Journal of Otorhinolaryngology-Head and Neck Surgery
Subjects:
chemoradiotherapy
oral mucositis
photobiomodulation therapy
squamous cell carcinoma of head and neck
Online Access:https://doi.org/10.1002/wjo2.18

Internet

https://doi.org/10.1002/wjo2.18

Similar Items